(Q70836356)
Statements
Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product? (English)
H Sancho-Garnier
J C Delarue
H Mouriesse
G Contesso
F May-Levin
M Gotteland